Trials / Unknown
UnknownNCT04427436
Novel Dementia Biomarkers
Investigating the Potential of Novel Dementia Biomarkers - an MRI, fNIRS and EEG Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- German Center for Neurodegenerative Diseases (DZNE) · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The study will investigate structural and functional characteristics of the brain of dementia patients compared to healthy controls in order to get a better insight into importance of early biomarkers for the diagnosis of Alzheimer's dementia. The methods for obtaining biomarkers incude magnetic resonance imaging (MRI), near-infrared spectroscopy (fNIRS) and electroencephalography (EEG), electrocardiography (ECG) and neurophyshological assessments. Special parameters are being studied that have already been shown to detect changes in the early stages of Alzheimer's dementia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | No Intervention |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2020-12-31
- Completion
- 2021-12-31
- First posted
- 2020-06-11
- Last updated
- 2020-06-11
Source: ClinicalTrials.gov record NCT04427436. Inclusion in this directory is not an endorsement.